Juan Vera
Director, Marker Therapeutics, Inc.
Companies
- Marker Therapeutics, Inc.Chief executive officer May 11, 2023 to now1
- Marker Therapeutics, Inc.President May 11, 2023 to now1
- Marker Therapeutics, Inc.Board member Oct 19, 2018 to now2
- Kalaris Therapeutics, Inc.Board member Jul 30, 2020 to Jun 7, 20243
- Marker Therapeutics, Inc.Chief operating officer Feb 22, 2022 to Mar 1, 20234
- Marker Therapeutics, Inc.Chief Development Officer Mar 12, 2020 to Mar 18, 20215
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Kalaris Therapeutics, Inc. KLRS2,409,928 shares6$5.3M at $2.19Jun 6, 2024
- Marker Therapeutics, Inc. MRKR2,671,845 shares7$2.5M at $0.92Mar 24, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 6, 2024Granted 35,000 shares of Kalaris Therapeutics, Inc.6
- May 11, 2023Granted 35,000 shares of Kalaris Therapeutics, Inc.8
- Mar 24, 2022Shares withheld for tax 33,465 shares at $0.48 of Marker Therapeutics, Inc.7
- Mar 24, 2022Granted 140,823 shares of Marker Therapeutics, Inc.7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8SEC EDGARForm 4 filed May 12, 2023